Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab

Update Il y a 4 ans
Reference: NCT00122304

Woman and Man

Extract

The primary objective is to evaluate the safety of eculizumab in patients with transfusion-dependent hemolytic PNH


Inclusion criteria

  • Hemoglobinuria, Paroxysmal


Links